Page last updated: 2024-09-03

olmesartan medoxomil and Aneurysm, Aortic

olmesartan medoxomil has been researched along with Aneurysm, Aortic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoka, Y; Aomi, S; Hagiwara, N; Kasanuki, H; Kawana, M; Nagashima, H; Sakomura, Y; Sakuta, A; Uto, K1

Other Studies

1 other study(ies) available for olmesartan medoxomil and Aneurysm, Aortic

ArticleYear
An angiotensin-converting enzyme inhibitor, not an angiotensin II type-1 receptor blocker, prevents beta-aminopropionitrile monofumarate-induced aortic dissection in rats.
    Journal of vascular surgery, 2002, Volume: 36, Issue:4

    Topics: Aminopropionitrile; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Aneurysm; Aortic Dissection; Disease Models, Animal; Imidazoles; Olmesartan Medoxomil; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles; Thiazepines

2002